Ubiquitin Receptors Play Redundant Roles in the Proteasomal Degradation of the P53 Repressor MDM2

Overview

Journal FEBS Lett

Specialty Biochemistry

Date 2022 Jun 23

PMID 35735670

Authors

Alison Sparks

Christopher J Kelly

Mark K Saville

Affiliations

Soon will be listed here.

Abstract

Much remains to be determined about the participation of ubiquitin receptors in proteasomal degradation and their potential as therapeutic targets. Suppression of the ubiquitin receptor S5A/PSMD4/hRpn10 alone stabilises p53/TP53 but not the key p53 repressor MDM2. Here, we observed S5A and the ubiquitin receptors ADRM1/PSMD16/hRpn13 and RAD23A and B functionally overlap in MDM2 degradation. We provide further evidence that degradation of only a subset of ubiquitinated proteins is sensitive to S5A knockdown because ubiquitin receptor redundancy is commonplace. p53 can be upregulated by S5A modulation while degradation of substrates with redundant receptors is maintained. Our observations and analysis of Cancer Dependency Map (DepMap) screens show S5A depletion/loss substantially reduces cancer cell line viability. This and selective S5A dependency of proteasomal substrates make S5A a target of interest for cancer therapy.

References

Mao Y . Structure, Dynamics and Function of the 26S Proteasome. Subcell Biochem. 2020; 96:1-151. DOI: 10.1007/978-3-030-58971-4_1. View

Lobato-Gil S, Heidelberger J, Maghames C, Bailly A, Brunello L, Rodriguez M . Proteome-wide identification of NEDD8 modification sites reveals distinct proteomes for canonical and atypical NEDDylation. Cell Rep. 2021; 34(3):108635. DOI: 10.1016/j.celrep.2020.108635. View

Chen X, Dorris Z, Shi D, Huang R, Khant H, Fox T . Cryo-EM Reveals Unanchored M1-Ubiquitin Chain Binding at hRpn11 of the 26S Proteasome. Structure. 2020; 28(11):1206-1217.e4. PMC: 7642156. DOI: 10.1016/j.str.2020.07.011. View

Ghandi M, Huang F, Jane-Valbuena J, Kryukov G, Lo C, McDonald 3rd E . Next-generation characterization of the Cancer Cell Line Encyclopedia. Nature. 2019; 569(7757):503-508. PMC: 6697103. DOI: 10.1038/s41586-019-1186-3. View

Carugo A, Minelli R, Sapio L, Soeung M, Carbone F, Robinson F . p53 Is a Master Regulator of Proteostasis in SMARCB1-Deficient Malignant Rhabdoid Tumors. Cancer Cell. 2019; 35(2):204-220.e9. PMC: 7876656. DOI: 10.1016/j.ccell.2019.01.006. View

Fu H, Lin Y, Fatimababy A . Proteasomal recognition of ubiquitylated substrates. Trends Plant Sci. 2010; 15(7):375-86. DOI: 10.1016/j.tplants.2010.03.004. View

Pacini C, Dempster J, Boyle I, Goncalves E, Najgebauer H, Karakoc E . Integrated cross-study datasets of genetic dependencies in cancer. Nat Commun. 2021; 12(1):1661. PMC: 7955067. DOI: 10.1038/s41467-021-21898-7. View

Gaczynska M, Osmulski P . Targeting Protein-Protein Interactions in the Proteasome Super-Assemblies. Curr Top Med Chem. 2015; 15(20):2056-67. DOI: 10.2174/1568026615666150519103206. View

Lee D, Takayama S, Goldberg A . ZFAND5/ZNF216 is an activator of the 26S proteasome that stimulates overall protein degradation. Proc Natl Acad Sci U S A. 2018; 115(41):E9550-E9559. PMC: 6187164. DOI: 10.1073/pnas.1809934115. View

10.

Tackmann N, Zhang Y . Mouse modelling of the MDM2/MDMX-p53 signalling axis. J Mol Cell Biol. 2017; 9(1):34-44. PMC: 5907827. DOI: 10.1093/jmcb/mjx006. View

11.

Lin Y, Sung S, Tsai H, Yu T, Radjacommare R, Usharani R . The defective proteasome but not substrate recognition function is responsible for the null phenotypes of the Arabidopsis proteasome subunit RPN10. Plant Cell. 2011; 23(7):2754-73. PMC: 3226219. DOI: 10.1105/tpc.111.086702. View

12.

Anchoori R, Karanam B, Peng S, Wang J, Jiang R, Tanno T . A bis-benzylidine piperidone targeting proteasome ubiquitin receptor RPN13/ADRM1 as a therapy for cancer. Cancer Cell. 2013; 24(6):791-805. PMC: 3881268. DOI: 10.1016/j.ccr.2013.11.001. View

13.

Zhang X, Su Y, Lin H, Yao X . The impacts of ubiquilin 1 (UBQLN1) knockdown on cells viability, proliferation, and apoptosis are mediated by p53 in A549 lung cancer cells. J Thorac Dis. 2020; 12(10):5887-5895. PMC: 7656338. DOI: 10.21037/jtd-20-1362. View

14.

Shimada M, Kanematsu K, Tanaka K, Yokosawa H, Kawahara H . Proteasomal ubiquitin receptor RPN-10 controls sex determination in Caenorhabditis elegans. Mol Biol Cell. 2006; 17(12):5356-71. PMC: 1687211. DOI: 10.1091/mbc.e06-05-0437. View

15.

Miyazaki Y, Chen L, Chu B, Swigut T, Wandless T . Distinct transcriptional responses elicited by unfolded nuclear or cytoplasmic protein in mammalian cells. Elife. 2015; 4. PMC: 4566031. DOI: 10.7554/eLife.07687. View

16.

Song Y, Park P, Wu L, Ray A, Picaud S, Li D . Development and preclinical validation of a novel covalent ubiquitin receptor Rpn13 degrader in multiple myeloma. Leukemia. 2019; 33(11):2685-2694. PMC: 6783320. DOI: 10.1038/s41375-019-0467-z. View

17.

Sun X, Butterworth M, MacFarlane M, Dubiel W, Ciechanover A, Cohen G . Caspase activation inhibits proteasome function during apoptosis. Mol Cell. 2004; 14(1):81-93. DOI: 10.1016/s1097-2765(04)00156-x. View

18.

Xie X, Matsumoto S, Endo A, Fukushima T, Kawahara H, Saeki Y . Deubiquitylases USP5 and USP13 are recruited to and regulate heat-induced stress granules through their deubiquitylating activities. J Cell Sci. 2018; 131(8). DOI: 10.1242/jcs.210856. View

19.

Dempster J, Boyle I, Vazquez F, Root D, Boehm J, Hahn W . Chronos: a cell population dynamics model of CRISPR experiments that improves inference of gene fitness effects. Genome Biol. 2021; 22(1):343. PMC: 8686573. DOI: 10.1186/s13059-021-02540-7. View

20.

Dayal S, Sparks A, Jacob J, Allende-Vega N, Lane D, Saville M . Suppression of the deubiquitinating enzyme USP5 causes the accumulation of unanchored polyubiquitin and the activation of p53. J Biol Chem. 2008; 284(8):5030-41. PMC: 2696100. DOI: 10.1074/jbc.M805871200. View